What is the creatinine clearance for a 156-pound elderly female patient with a serum creatinine level of 1.03 mg/dL and a glomerular filtration rate (GFR) of 55 mL/min/1.73m^2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Creatinine Clearance Calculation

For this 156-pound female patient with serum creatinine 1.03 mg/dL, the creatinine clearance is approximately 52 mL/min using the Cockcroft-Gault formula, which is the recommended method for medication dosing decisions. 1

Calculation Using Cockcroft-Gault Formula

The American College of Cardiology recommends using the Cockcroft-Gault formula to estimate creatinine clearance: CrCl (mL/min) = [(140 - age) × weight (kg)] / [72 × serum creatinine (mg/dL)] × (0.85 if female). 1

Converting the patient's weight:

  • 156 pounds = 70.8 kg 1

Assuming a typical elderly age (e.g., 70 years) for calculation:

  • CrCl = [(140 - 70) × 70.8] / [72 × 1.03] × 0.85
  • CrCl = [70 × 70.8] / 74.16 × 0.85
  • CrCl = 4,956 / 74.16 × 0.85
  • CrCl ≈ 52 mL/min 1

Critical Clinical Context

The reported GFR of 55 mL/min/1.73m² is NOT the same as creatinine clearance. 1 GFR represents the true rate at which kidneys filter blood through the glomeruli and is indexed to body surface area, while creatinine clearance measures how quickly creatinine is removed from blood and includes both glomerular filtration AND tubular secretion. 1

Why This Distinction Matters for Medication Dosing

  • For medication dosing, always use Cockcroft-Gault-derived creatinine clearance (approximately 52 mL/min in this case), NOT the reported eGFR of 55 mL/min/1.73m². 1 Drug manufacturers and pharmacokinetic studies have traditionally used the Cockcroft-Gault formula to establish renal dosing guidelines for most medications. 1

  • Using normalized eGFR for drug dosing leads to underdosing in larger patients and overdosing in smaller patients. 1

Critical Pitfalls in Elderly Patients

Never rely on serum creatinine alone in elderly patients—a "normal" creatinine of 1.03 mg/dL can represent significant renal impairment. 1, 2 Among elderly patients with normal serum creatinine measurements, one in five had asymptomatic renal insufficiency when assessed by creatinine clearance methods. 2

Age-Related Considerations

  • The Cockcroft-Gault formula consistently underestimates GFR in elderly patients, with the discrepancy most pronounced in the oldest patients. 3, 1

  • At this level of renal function (CrCl ~52 mL/min), the formula may actually overestimate true GFR due to increased tubular secretion of creatinine that occurs at low levels of renal function. 3

  • Serum creatinine production decreases with age-related muscle mass loss independently of kidney function, making a creatinine of 1.03 mg/dL potentially represent moderate renal impairment in an elderly female. 1, 2

Clinical Implications for This Patient

This patient has Stage 3A chronic kidney disease (CrCl 45-59 mL/min) and requires dose adjustment for all renally cleared medications. 2

Immediate Actions Required

  • Review all current medications within 48 hours to prevent adverse drug reactions and acute kidney injury, focusing on nephrotoxic agents such as NSAIDs, ACE inhibitors, and diuretics. 2

  • Calculate specific dose adjustments for renally cleared medications using the Cockcroft-Gault-derived creatinine clearance of approximately 52 mL/min, not the reported eGFR. 1, 2

  • Avoid co-administration of nephrotoxic medications, particularly NSAIDs or COX-2 inhibitors. 1

Monitoring Recommendations

  • Assess and optimize hydration status, as dehydration can falsely elevate creatinine and reduce GFR in elderly patients. 1, 2

  • Repeat creatinine and eGFR in 3 months to establish trajectory of kidney function. 2

  • Perform annual urinalysis with urine albumin-to-creatinine ratio to assess proteinuria and CKD progression risk. 2

References

Guideline

Estimating Creatinine Clearance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment for Stage 3a CKD in an Elderly Female

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the estimated creatinine clearance for a 63-year-old female patient weighing 79 kg with a serum creatinine level of 1.2?
What is the estimated creatinine clearance for an 82-year-old male, 5'4" tall, weighing 130 pounds, with a serum creatinine of 3.8 mg/dL and a BUN (Blood Urea Nitrogen) of 31 mg/dL?
What is the estimated creatinine clearance (CrCl) for an elderly female, 5 foot 3, 105 pounds, with a serum creatinine (Scr) level of 1.42?
What is the estimated creatinine clearance for a male in their late 80s, with a creatinine level of 1.85 mg/dL and a height of 178 cm?
What is the creatinine result in mg/24 hour (milligrams per 24 hours) for a 24-hour urine collection with a total volume of 1260 milliliters (mL) and a creatinine concentration of 74 milligrams per deciliter (mg/dL)?
What is the best PRN (pro re nata) medication for acute anger and irritability in a 14-year-old male patient who is allergic to lithium and has just started on sertraline (Zoloft) 25mg?
What are the alternative treatment options for a patient with dyslipidemia who is intolerant to statins and ezetimibe (Zetia)?
What are the implications and management of an elevated Blood Urea Nitrogen (BUN)/creatinine ratio, particularly in elderly patients or those with a history of cardiovascular disease?
What is the recommended treatment regimen for a patient with Human Immunodeficiency Virus (HIV)?
What is the prevalence of insulin resistance in the Mexican population?
What is the best alternative medication for a patient with type 2 diabetes mellitus (DM 2) who is experiencing negative effects from metformin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.